Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 5/16/2025WuXi Biologics Offloads German Plant to Terumo, Refocuses on Singapore...
  • 5/16/2025Viva Biotech Unveils Proprietary AI Platform to Reshape Drug Discovery
  • 5/16/2025Nuance Pharma Reports Positive Phase 3 Results for Ensifentrine in Chi...
  • 5/16/2025US Push to Decouple from China May Spike Drug Costs, Experts Warn
  • 5/16/2025NMPA Orders Package Insert/Label Update for Ranitidine Injection Amid ...
  • 5/16/2025NMPA Approves CANbridge's Velaglucerase Beta for Gaucher Disease
  • 5/16/2025China Approves Xuanzhu Bio's Birociclib for HR+/HER2- Advanced Breast ...
  • 5/16/2025CSPC and Cipla Forge Exclusive U.S. Licensing Deal for Irinotecan Lipo...
  • 5/16/2025China Approves Haisco Pharma's Anrikefon (HSK21542) for Postoperative ...
  • 5/16/2025ArkBio Reports Positive Mid-Stage Results for Anti-Fibrotic Candidate ...
  • 5/15/2025Hengrui Aims to Raise $1.27B in Hong Kong IPO
  • 5/15/2025NMPA Approves Novartis' Scemblix for First-Line Treatment of Chronic M...
  • 5/15/2025Novartis Gains NMPA Approval for Expanded Use of Kisqali in Early Brea...
  • 5/14/2025Chinese Drugmakers May Weather Trump's Tariff Threats With Cost Edge, ...
  • 5/14/2025CDE Issues the List of Reference Formulations for GQCE Studies (92nd B...
  • 5/14/2025R&D Spending Rises at 276 Chinese Drugmakers Despite Revenue Pressures
  • 5/14/2025Six Drugs Granted Priority Review as China Registers Over 1,100 Produc...
  • 5/14/2025Beigene Submits New Indication Application for BCL2 Inhibitor Sonrotoc...
  • 5/14/2025CTTQ's Anlotinib-Penpulimab Combo Extends Survival in First-Line Advan...
  • 5/14/2025RemeGen's Disitamab Vedotin Plus Toripalimab Shows Promise for HER2-Po...
  • 5/14/2025Beam Secures RMAT Designation for BEAM-302, a Base Editing Therapy for...
  • 5/14/2025BRL Medicine's Allogeneic CAR-T Therapy Shows Promising Results in Ref...
  • 5/14/2025NMPA Approves IND for YL242: An ADC Targeting Soluble VEGF M
  • 5/13/2025China Expands Geriatric Services at Major Hospitals as Elderly Populat...
  • 5/12/2025Chinese Pharma Firms Expected to Withstand Trump's Drug Price Crackdow...
  • 5/12/2025METiS Eyes US$200M Hong Kong IPO as AI Drug Sector Heats Up
  • 5/12/2025Regenverse Raises ~CNY 100M in Pre-A Financing to Advance Regenerative...
  • 5/12/2025EndoCell Secures ~CNY 200M in Dual-Round Financing to Accelerate Cell ...
  • 5/12/2025China Biopharma Financing Drops in April 2025, Signals Investor Cautio...
  • 5/12/2025CARsgen Reports Encouraging Early Data for Allogeneic BCMA CAR-T CT059...
  • Page:5/51 Total number of articles:1508: [First][<<] [3] [4] [5] [6] [7] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group